Companies › AVR
ANTERIS TECHNOLOGIES GLOBAL (AVR)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0002011514 · EDGAR filings · Updated 2026-07-28
ANTERIS TECHNOLOGIES GLOBAL (AVR) has reported institutional ownership of 66.0%, with 127 institutional managers holding positions valued at $356.0M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).
Filings this week (2)
- 2026-07-28 — 4/A filed
- 2026-07-28 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-01 — S-3ASR filed
- 2026-06-09 — Insider transaction reported (Form 4)
- 2026-06-09 — Insider transaction reported (Form 4)
- 2026-06-09 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ANTERIS TECHNOLOGIES GLOBAL has 127 institutional holders and institutional ownership of 66.0%.
Insider activity
Insiders reported 7 transactions (1 buys, 0 sells) across 6 reporting insiders, with a net reported value of $28.8M.
Data flags from SEC filings
Related companies
NATURES SUNSHINE PRODS INC (NATR) · SHATTUCK LABS INC (STTK) · EMERGENT BIOSOLUTIONS INC (EBS) · REGENXBIO INC (RGNX) · SUTRO BIOPHARMA INC (STRO) · FORTE BIOSCIENCES INC (FBRX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.